Attached files

file filename
EX-32.2 - EXHIBIT 32.2 - LIQUIDMETAL TECHNOLOGIES INCex_183079.htm
EX-32.1 - EXHIBIT 32.1 - LIQUIDMETAL TECHNOLOGIES INCex_183078.htm
EX-31.2 - EXHIBIT 31.2 - LIQUIDMETAL TECHNOLOGIES INCex_183077.htm
EX-31.1 - EXHIBIT 31.1 - LIQUIDMETAL TECHNOLOGIES INCex_183076.htm
 

 

Table of Contents

UNITED STATES


SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

For the quarterly period ended March 31, 2020

 

 

OR

 

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

For the transition period from          to         

 

Commission File No001-31332


LIQUIDMETAL TECHNOLOGIES, INC.

(Exact name of Registrant as specified in its charter)

 

Delaware

33-0264467

(State or other jurisdiction of

(I.R.S. Employer

incorporation or organization)

Identification No.)

 

20321 Valencia Circle

Lake Forest, CA 92630

(Address of principal executive offices, zip code)

 

Registrant’s telephone number, including area code: (949) 635-2100 


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes      No  

 

Indicate by check mark whether the registrant has submitted every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). 

Yes      No  

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer            Accelerated filer             Non-accelerated filer

 

Smaller reporting company             Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). 

Yes       No  

 

Securities registered pursuant to Section 12(b) of the Exchange Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common stock, $0.001 par value per share

LQMT

OTCQB 

 

The number of common shares outstanding as of May 1, 2020 was 914,449,957.

 

 

 

LIQUIDMETAL TECHNOLOGIES, INC.
FORM 10-Q
FOR THE QUARTER ENDED
March 31, 2020



FORWARD-LOOKING INFORMATION

 

This Quarterly Report on Form 10-Q of Liquidmetal Technologies, Inc. contains “forward-looking statements” that may state our management’s plans, future events, objectives, current expectations, estimates, forecasts, assumptions or projections about the company and its business. Any statement in this report that is not a statement of historical fact is a forward-looking statement, and in some cases, words such as “believes,” “estimates,” “projects,” “expects,” “intends,” “may,” “anticipates,” “plans,” “seeks,” and similar words or expressions identify forward-looking statements. Forward-looking statements involve risks and uncertainties that could cause actual outcomes and results to differ materially from the anticipated outcomes or results. These statements are not guarantees of future performance, and undue reliance should not be placed on these statements. It is important to note that our actual results could differ materially from what is expressed in our forward-looking statements due to the risk factors described in the section of our Annual Report on Form 10-K for the year ended December 31, 2019 entitled “Risk Factors,” as well as the following risks and uncertainties:

 

 

Our ability to fund our operations in the long-term through financing transactions on terms acceptable to us, or at all;

 

Our history of operating losses and the uncertainty surrounding our ability to achieve or sustain profitability;

 

Our limited history of developing and selling products made from our bulk amorphous alloys;

 

Challenges associated with having products manufactured from our alloys and the use of third parties for manufacturing;

 

Our limited history of licensing our technology to third parties;

 

Lengthy customer adoption cycles and unpredictable customer adoption practices;

 

Our ability to identify, develop, and commercialize new product applications for our technology;

 

Competition from current suppliers of incumbent materials or producers of competing products;

 

Our ability to identify, consummate, and/or integrate strategic partnerships;

 

The potential for manufacturing problems or delays;

 

Potential difficulties associated with protecting or expanding our intellectual property position; and

 

Economic and business uncertainties relating to the COVID-19 pandemic.

 

We undertake no obligation, other than as required by applicable law, to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

 

 

 

 

TABLE OF CONTENTS

 

 

 

 

PART I - Financial Information

 

 

 

 

 

 

Item 1 – Financial Statements

4

 

 

Consolidated Balance Sheets

4

 

 

Consolidated Statements of Operations

5

 

 

Consolidated Statements of Comprehensive Loss

6

 

 

Consolidated Statements of Cash Flows

7

 

 

Notes to Consolidated Financial Statements

8

 

 

 

 

 

Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations

17

 

 

 

 

 

Item 3 – Quantitative and Qualitative Disclosures about Market Risk

22

 

 

 

 

 

Item 4 – Controls and Procedures

22

 

 

 

 

PART II – Other Information

 

 

 

 

 

 

Item 1 – Legal Proceedings

23

 

 

 

 

 

Item 1A – Risk Factors

23

 

 

 

 

 

Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds

23

 

 

 

 

 

Item 3 – Defaults Upon Senior Securities

23

 

 

 

 

 

Item 4 – Mine Safety Disclosures

23

 

 

 

 

 

Item 5 – Other Information

23

 

 

 

 

 

Item 6 – Exhibits

24

 

 

 

 

Signatures

25

 

 

 

PART I

FINANCIAL INFORMATION

Item 1 – Financial Statements

 

 

LIQUIDMETAL TECHNOLOGIES, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

($ in thousands, except par value and share data)

 

   

March 31,

   

December 31,

 
   

2020

   

2019

 
      (Unaudited)       (Audited)  

ASSETS

               
                 

Current assets:

               

Cash and cash equivalents

  $ 19,664     $ 19,543  

Restricted cash

    5       5  

Investments in debt securities- short term

    4,970       4,415  

Trade accounts receivable, net of allowance for doubtful accounts

    273       303  

Inventory

    -       12  

Prepaid expenses and other current assets

    293       322  

Total current assets

  $ 25,205     $ 24,600  

Investments in debt securities- long term

    5,533       7,074  

Property and equipment, net

    8,832       8,819  

Patents and trademarks, net

    218       239  

Equipment held for sale

    585       585  

Other assets

    137       14  

Total assets

  $ 40,510     $ 41,331  
                 

LIABILITIES AND SHAREHOLDERS' EQUITY

               
                 

Current liabilities:

               

Accounts payable

    81       132  

Accrued liabilities

    712       775  

Total current liabilities

  $ 793     $ 907  
                 

Long-term liabilities

               

Other long-term liabilities

    899       856  

Total liabilities

  $ 1,692     $ 1,763  
                 

Shareholders' equity:

               

Preferred Stock, $0.001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

    -       -  

Common stock, $0.001 par value; 1,100,000,000 shares authorized; 914,449,957 and 914,449,957 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

    914       914  

Warrants

    18,179       18,179  

Additional paid-in capital

    286,924       286,832  

Accumulated deficit

    (267,030 )     (266,284 )

Accumulated other comprehensive income (loss)

    (94 )     2  

Non-controlling interest in subsidiary

    (75 )     (75 )

Total shareholders' equity

  $ 38,818     $ 39,568  
                 

Total liabilities and shareholders' equity

  $ 40,510     $ 41,331  

 

The accompanying notes are an integral part of the consolidated financial statements.

 

 

 

LIQUIDMETAL TECHNOLOGIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS 

($ in thousands, except share and per share data)

(unaudited)

 

   

For the Three Months
Ended March 31,

 
   

2020

   

2019

 
                 

Revenue

               

Products

  $ 46     $ 223  

Licensing and royalties

    25       -  

Total revenue

    71       223  
                 

Cost of sales

    36       179  

Gross profit

    35       44  
                 

Operating expenses

               

Selling, marketing, general and administrative

    987       1,433  

Research and development

    29       489  

Gain on disposal of long-lived assets

    (20 )     -  

Total operating expenses

    996       1,922  

Operating loss

    (961 )     (1,878 )
                 

Lease income

    88       -  

Interest and investment income

    127       110  
                 

Loss before income taxes

    (746 )     (1,768 )
                 

Income taxes

    -       -  
                 

Net loss

    (746 )     (1,768 )
                 

Net loss attributable to non-controlling interest

    -       -  

Net loss attributable to Liquidmetal Technologies shareholders

  $ (746 )   $ (1,768 )
                 
                 

Per common share basic and diluted:

               
                 

Net loss per common share attributable to Liquidmetal Technologies shareholders, basic and diluted

  $ (0.00 )   $ (0.00 )
                 

Number of weighted average shares - basic and diluted

    914,449,957       914,280,027  

 

The accompanying notes are an integral part of the consolidated financial statements.

 

 

 

LIQUIDMETAL TECHNOLOGIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

($ in thousands, except share and per share data)

(unaudited)

 

   

For the Three Months
Ended March 31,

 
   

2020

   

2019

 
                 

Net loss

  $ (746 )   $ (1,768 )

Other comprehensive loss, net of tax

               

Net unrealized losses on available-for-sale securities

    (96 )     -  

Other comprehensive income, net of tax

    (96 )     -  

Comprehensive loss

  $ (842 )   $ (1,768 )

Less: Comprehensive loss attributable to noncontrolling interests

    -       -  

Comprehenisve loss attributable to Liquidmetal Technologies shareholders

  $ (842 )   $ (1,768 )

 

The accompanying notes are an integral part of the consolidated financial statements.

 

 

 

LIQUIDMETAL TECHNOLOGIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

($ in thousands, except per share data)

(unaudited)

 

   

For the Three Months Ended March 31,

 
   

2020

   

2019

 
                 

Operating activities:

               

Net loss

  $ (746 )   $ (1,768 )
                 

Adjustments to reconcile net loss to net cash used in operating activities:

               

Depreciation and amortization

    101       279  

Realized investment gains

    (1 )     -  

Stock-based compensation

    92       182  

Gain on disposal of long-lived assets

    (20 )     -  
                 

Changes in operating assets and liabilities:

               

Trade accounts receivable

    30       (4 )

Inventory

    12       (32 )

Prepaid expenses and other current assets

    29       52  

Other assets and liabilities

    (80 )     -  

Accounts payable and accrued liabilities

    (114 )     109  

Deferred revenue

    -       (3 )

Net cash used in operating activities

    (697 )     (1,185 )
                 

Investing Activities:

               

Purchases of property and equipment

    (93 )     (184 )

Proceeds from disposal of fixed assets

    20       -  

Purchases of debt securities

    (1,654 )     -  

Proceeds from sales of debt securities

    2,545       -  

Net cash provided by (used in) investing activities

    818       (184 )
                 

Financing Activities:

               

Proceeds from exercise of stock options

    -       11  

Net cash provided by financing activities

    -       11  
                 

Net decrease in cash, cash equivalents, and restricted cash

    121       (1,358 )
                 

Cash, cash equivalents, and restricted cash at beginning of period

    19,548       35,234  

Cash, cash equivalents, and restricted cash at end of period

  $ 19,669     $ 33,876  
                 

Supplemental Schedule of Non-Cash Financing Activities:

               

Accrued capital expenditures

    -       (36 )

 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

7

LIQUIDMETAL TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
For the Three Months Ended March 31, 2020 and 2019
(numbers in thousands, except percentages, share and per share data)
(unaudited)

 

 

1. Description of Business

 

Liquidmetal Technologies, Inc. (the “Company”) is a materials technology company that develops and commercializes products made from amorphous alloys. The Company’s family of alloys consists of a variety of bulk alloys and composites that utilize the advantages offered by amorphous alloys technology. The Company designs, develops, and sells products and custom parts from bulk amorphous alloys to customers in a wide range of industries. The Company also partners with third-party manufacturers and licensees to develop and commercialize Liquidmetal alloy products.

 

Amorphous alloys are, in general, unique materials that are distinguished by their ability to retain a random atomic structure when they solidify, in contrast to the crystalline atomic structure that forms in other metals and alloys when they solidify. Liquidmetal alloys are proprietary amorphous alloys that possess a combination of performance, processing, and potential cost advantages that the Company believes will make them preferable to other materials in a variety of applications. The amorphous atomic structure of bulk alloys enables them to overcome certain performance limitations caused by inherent weaknesses in crystalline atomic structures, thus facilitating performance and processing characteristics superior in many ways to those of their crystalline counterparts. The Company believes that the alloys and the molding technologies it employs may result in components, for many applications, that exhibit: exceptional dimensional control and repeatability that rivals precision machining, excellent corrosion resistance, brilliant surface finish, high strength, high hardness, high elastic limit, alloys that are non-magnetic, and the ability to form complex shapes common to the injection molding of plastics. Interestingly, all of these characteristics are achievable from the molding process, so design engineers often do not have to select specific alloys to achieve one or more of the characteristics as is the case with crystalline materials. The Company believes these advantages could result in Liquidmetal alloys supplanting high-performance alloys, such as titanium and stainless steel, and other incumbent materials in a wide variety of applications. Moreover, the Company believes these advantages could enable the introduction of entirely new products and applications that are not possible or commercially viable with other materials.

 

The Company’s revenues are derived from i) selling bulk Liquidmetal alloy products to customers who produce medical devices, automotive assemblies, sports and leisure goods, and non-consumer electronic devices, ii) selling tooling and prototype parts such as demonstration parts and test samples for customers with products in development, iii) product licensing and royalty revenue, and iv) research and development revenue. The Company expects that these sources of revenue will continue to significantly change the character of the Company’s revenue mix.

 

 

2. Basis of Presentation and Recent Accounting Pronouncements

 

The accompanying unaudited interim consolidated financial statements as of and for the three months ended March 31, 2020 and March 31, 2019 have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q. Accordingly, they do not include all of the information and notes required by US GAAP for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring accruals) considered necessary for a fair presentation have been included. All intercompany balances and transactions have been eliminated in consolidation. Operating results for the three months ended March 31, 2020 are not necessarily indicative of the results that may be expected for any future periods or the year ending December 31, 2020. The accompanying unaudited consolidated financial statements should be read in conjunction with the Company's 2019 Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 10, 2020.

 

Investments in Debt Securities

 

The Company will invest excess funds to maximize investment yield, while maintaining liquidity and minimizing credit risk. Debt securities are carried at fair value and consist primarily of investments in obligations of the United States Treasury, various U.S. and foreign corporations, and certificates of deposits. The Company classifies its investments in debt securities as available-for-sale with all unrealized gains or losses included as part of other comprehensive income. The Company evaluates its debt securities with unrealized losses on a quarterly basis for potential other-than-temporary impairments in value. As a result of this assessment, the Company did not recognize any other-than-temporary impairment losses considered to be credit related for the three months ended March 31, 2020 and 2019.

 

Fair Value Measurements

 

The estimated fair values of financial instruments reported in the consolidated financial statements have been determined using available market information and valuation methodologies, as applicable. The fair value of cash and restricted cash approximate their carrying value due to their short maturities and are classified as Level 1 instruments within the fair value hierarchy.

 

8

LIQUIDMETAL TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
For the Three Months Ended March 31, 2020 and 2019
(numbers in thousands, except percentages, share and per share data)
(unaudited)

 

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Entities are required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value based upon the following fair value hierarchy:

 

Level 1 —

Quoted prices in active markets for identical assets or liabilities;

 

Level 2 —

Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and

 

Level 3 —

Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

 

As of March 31, 2020, the following table represents the Company’s fair value hierarchy for items that are required to be measured at fair value on a recurring basis:

 

   

Fair Value

   

Level 1

   

Level 2

   

Level 3

 
                                 

Investments in debt securities (short-term)

  $ 4,970     $ 1,013     $ 3,957     $ -  

Investments in debt securities (long-term)

    5,533       720       4,813       -  

 

 

As of December 31, 2019, the following table represents the Company’s fair value hierarchy for items that are required to be measured at fair value on a recurring basis:

 

   

Fair Value

   

Level 1

   

Level 2

   

Level 3

 
                                 

Investments in debt securities (short-term)

  $ 4,415     $ 705     $ 3,710     $ -  

Investments in debt securities (long-term)

    7,074       908       6,166       -  

 

Leases

 

The Company leases its previous manufacturing facility under a long-term contract, which is accounted for as an operating lease. The lease provides for a fixed base rent and variable payments comprised of reimbursements for property taxes, insurance, utilities, and common area maintenance. The lease has a term of sixty-two months, exclusive of options to renew. In accordance with ASC 842 Leases, lease income, which includes escalating rents over the term of the lease, is recorded on a straight-line basis over the expected lease term. The difference between lease income and payments received is recorded as a rent receivable, which is included as a prepaid expense in the consolidated balance sheets. Amounts paid for broker commissions represent prepaid direct lease costs, and will be amortized as an offset to lease income over the lease term.

 

Other Recent Pronouncements

 

Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants and the SEC did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statements.

 

9

LIQUIDMETAL TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
For the Three Months Ended March 31, 2020 and 2019
(numbers in thousands, except percentages, share and per share data)
(unaudited)

 

 

3. Significant Transactions

 

2019 Restructuring Plan

 

In July 2019, the Company adopted a restructuring plan pursuant to which the Company elected to wind down its prior manufacturing operations at the Company’s Lake Forest, CA facility and proceeded to outsource the manufacture of parts utilizing the Company’s technology through its domestic and international manufacturing partners (the “2019 Restructuring Plan”). In connection with the 2019 Restructuring Plan, the Company shifted its business strategy from internal manufacture of parts and products for customers toward the use and reliance of outsourced manufacturers, which will initially be Dongguan Yihao Metals Materials Technology Co., Ltd. (“Yihao”), a China-based company that is an affiliate of our largest beneficial stockholder, CEO and Chairman, Professor Lugee Li.

 

Manufacturing Facility Purchase

 

On February 16, 2017, the Company purchased a 41,000 square foot manufacturing facility located in Lake Forest, CA, where operations commenced during July 2017. The purchase price for the property was $7,818. As a result of the 2019 Restructuring Plan, the Company discontinued manufacturing operations in this facility during Q4 2019.

 

Facility Lease

 

On January 23, 2020, 20321 Valencia, LLC, a Delaware limited liability company and wholly owned subsidiary of the Company, entered into a lease agreement (the “Facility Lease”) pursuant to which the Company leased to MatterHackers, Inc., a Delaware corporation (“Tenant”), an approximately 32,534 square foot portion of a light industrial and office building owned by the Company. The lease term is for 5 years and 2 months, with stated rights for early occupancy, with full occupancy commencing on March 1, 2020. The base rent payable under the Facility Lease is $32,534 per month initially and is subject to periodic increases up to a maximum of approximately $54,000 per month. Tenant will pay approximately 79% of common operating expresses. The Facility Lease has other customary provisions, including provisions relating to default and usage restrictions. The Facility Lease grants to Tenant a right to extend the lease for one additional 60-month period at market rental value.

 

2016 Purchase Agreement

 

On March 10, 2016, the Company entered into a Securities Purchase Agreement (the “2016 Purchase Agreement”) with Liquidmetal Technology Limited, a Hong Kong company (the “Investor”), which is controlled by the Company’s Chairman and CEO, Professor Lugee Li (“Professor Li”). The 2016 Purchase Agreement provided for the purchase by the Investor of a total of 405,000,000 shares of the Company’s common stock for an aggregate purchase price of $63,400. The transaction occurred in multiple closings, with the Investor having purchased 105,000,000 shares at a purchase price of $8,400 (or $0.08 per share) at the initial closing on March 10, 2016 and the remaining 200,000,000 shares at $0.15 per share and 100,000,000 shares at $0.25 per share for an aggregate purchase price of $55,000 on October 26, 2016.

 

In addition to the shares issuable under the 2016 Purchase Agreement, the Company issued to the Investor a warrant to acquire 10,066,809 shares of common stock (of which the right to exercise 2,609,913 of the warrant shares vested on March 10, 2016 and the right to exercise the remaining 7,456,896 warrant shares vested on October 26, 2016 at an exercise price of $0.07 per share). The warrant will expire on the tenth anniversary of its issuance date.

 

Further, the 2016 Purchase Agreement provided that the Investor would have the right to designate three members of the Company’s board of directors, with one such member serving as Chairman. The 2016 Purchase Agreement also provided that, with certain limited exceptions, if the Company issues any shares of common stock at any time through the fifth anniversary of the 2016 Purchase Agreement, the Investor will have a preemptive right to subscribe for and to purchase at the same price per share (or at market price, in the case of issuance of shares pursuant to stock options) the number of shares necessary to maintain its ownership percentage of Company-issued shares of common stock.

 

Eontec License Agreement

 

On March 10, 2016, in connection with the 2016 Purchase Agreement, the Company and DongGuan Eontec Co., Ltd., a Hong Kong corporation (“Eontec”), entered into a Parallel License Agreement (the “License Agreement”) pursuant to which the Company and Eontec agreed to cross-license their respective technologies. The Company’s Chairman and CEO, Professor Li, is also a major shareholder and Chairman of Eontec.

 

The License Agreement provides for the cross-license of certain patents, technical information, and trademarks between the Company and Eontec. In particular, the Company granted to Eontec a paid-up, royalty-free, perpetual license to the Company’s patents and related technical information to make, have made, use, offer to sell, sell, export, and import products in certain geographic areas outside of North America and Europe. In turn, Eontec granted to the Company a paid-up, royalty-free, perpetual license to Eontec’s patents and related technical information to make, have made, use, offer to sell, sell, export, and import products in certain geographic areas outside of specified countries in Asia. The license granted by the Company to Eontec is exclusive (including to the exclusion of the Company) in the countries of Brunei, Cambodia, China (P.R.C and R.O.C.), East Timor, Indonesia, Japan, Laos, Malaysia, Myanmar, Philippines, Singapore, South Korea, Thailand, and Vietnam. The license granted by Eontec to the Company is exclusive (including to the exclusion of Eontec) in North America and Europe. The cross-licenses are non-exclusive in geographic areas outside of the foregoing exclusive territories.

 

Beyond the License Agreement, the Company collaborates with Eontec to accelerate the commercialization of amorphous alloy technology. This includes but is not limited to developing technologies to reduce the cost of amorphous alloys, working on die cast machine technology platforms to pursue broader markets, sharing knowledge to broaden our intellectual property portfolio, and utilizing Eontec’s volume production capabilities as a third party contract manufacturer.

 

10

LIQUIDMETAL TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
For the Three Months Ended March 31, 2020 and 2019
(numbers in thousands, except percentages, share and per share data)
(unaudited)

 

Eutectix Business Development Agreement

 

On January 31, 2020, the Company entered into a Business Development Agreement (the “Agreement”) with Eutectix, LLC, a Delaware limited liability company (“Eutectix”), which provides for collaboration, joint development efforts, and the manufacturing of products based on the Company’s proprietary amorphous metal alloys. Under the Agreement, the Company has agreed to license to Eutectix specified equipment owned by the Company, including two injection molding machines, two diecasting machines, and other machines and equipment, all of which will be used to make product for Company customers and Eutectix customers. The licensed machines and equipment represent substantially all of the machinery and equipment currently held by the Company. The Company has also licensed to Eutectix various patents and technical information related to the Company’s proprietary technology. Under the Agreement, Eutectix will pay the Company a royalty of six percent (6%) of the net sales price of licensed products sold by Eutectix, and Eutectix will also manufacture for the Company product ordered by the Company. The Agreement has a term of five years, subject to renewal provisions and the ability of either party to terminate earlier upon specified circumstances.

 

Apple License Transaction

 

On August 5, 2010, the Company entered into a license transaction with Apple Inc. (“Apple”) pursuant to which (i) the Company contributed substantially all of its intellectual property assets to a newly organized special-purpose, wholly-owned subsidiary, called Crucible Intellectual Property, LLC (“CIP”), (ii) CIP granted to Apple a perpetual, worldwide, fully-paid, exclusive license to commercialize such intellectual property in the field of consumer electronic products, as defined in the license agreement, in exchange for a license fee, and (iii) CIP granted back to the Company a perpetual, worldwide, fully-paid, exclusive license to commercialize such intellectual property in all other fields of use.

 

Under the agreements relating to the license transaction with Apple, the Company was obligated to contribute, to CIP, all intellectual property developed through February 2016. The Company is also obligated to maintain certain limited liability company formalities with respect to CIP at all times after the closing of the license transaction.

 

Other License Transactions

 

On January 31, 2012, the Company entered into a Supply and License Agreement for a five year term with Engel Austria Gmbh (“Engel”) whereby Engel was granted a non-exclusive license to manufacture and sell injection molding machines to the Company’s licensees. On December 6, 2013, the Company and Engel entered into an Exclusivity Agreement for a ten year term whereby the Company agreed, with certain exceptions and limitations, that the Company and its licensees would purchase amorphous alloy injection molding machines exclusively from Engel.

 

The Company’s majority-owned Liquidmetal Golf subsidiary has the exclusive right and license to utilize the Company’s Liquidmetal alloy technology for purposes of golf equipment applications. This right and license is set forth in an intercompany license agreement between Liquidmetal Technologies and Liquidmetal Golf. This license agreement provides that Liquidmetal Golf has a perpetual and exclusive license to use Liquidmetal alloy technology for the purpose of manufacturing, marketing, and selling golf club parts and other products used in the sport of golf. The Company owns 79% of the outstanding common stock of Liquidmetal Golf.

 

In March 2009, the Company entered into a license agreement with Swatch Group, Ltd. (“Swatch”) under which Swatch was granted a non-exclusive license to the Company’s technology to produce and market watches and certain other luxury products. In March 2011, this license agreement was amended to grant Swatch exclusive rights as to watches, but non-exclusive as to Apple. The Company will receive royalty payments over the life of the contract on all Liquidmetal products produced and sold by Swatch. The license agreement with Swatch will expire on the expiration date of the last licensed patent.

 

11

LIQUIDMETAL TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
For the Three Months Ended March 31, 2020 and 2019
(numbers in thousands, except percentages, share and per share data)
(unaudited)

 

 

 

4. Investments in debt securities

 

The following table sets forth amortized cost fair value, and unrealized gains (losses) of investments in debt securities (short-term and long-term):

 

     

Amortized Cost

   

Fair Value

   

Unrealized gains (losses)

 
  Longest  

March 31,

   

December 31,

   

March 31,

   

December 31,

   

March 31,

   

December 31,

 
 

Maturity Date

 

2020

   

2019

   

2020

   

2019

   

2020

   

2019

 
                                                   

U.S. government and agency securities

2022

  $ 1,710     $ 1,612     $ 1,733     $ 1,612     $ 23     $ -  

Corporate bonds

2023

    7,287       7,474       7,169       7,476       (118 )     2  

Certificates of deposit

One-year

    1,600       2,400       1,601       2,400       1       -  
      $ 10,597     $ 11,486     $ 10,503     $ 11,488     $ (94 )   $ 2  

 

Income from these investments totaled $68 and $0 during the three months ended March 31, 2020 and 2019, respectively, and was included as a portion of interest and investment income on the Company’s consolidated statements of operations.

 

Based on the Company’s review of its debt securities in an unrealized loss position at March 31, 2020, it determined that the losses were primarily the result current economic factors, impacting all global debt and equity markets, that are the result of the global COVID-19 pandemic. The impact to the Company’s investment portfolio is considered to be temporary, rather than a deterioration of overall credit quality. As of March 31, 2020, all investments are current on their schedule interest and dividend payments and the Company expects that recent government stimulus actions will further strengthen these securities. The Company does not intend to sell and it is not more likely than not that the Company will be required to sell these securities prior to recovering their amortized cost. As such, the Company does not consider these securities to be other-than-temporarily impaired at March 31, 2020.

 

 

5. Prepaid Expenses and Other Current Assets

 

Prepaid expenses and other current assets totaled $293 and $322 as of March 31, 2020 and December 31, 2019, respectively. Included within these totals are the following:

 

   

March 31,

   

December 31,

 
   

2020

   

2019

 
                 

Prepaid service invoices

  $ 72     $ 42  

Prepaid insurance premiums

    124       198  

Prepaid lease costs and receivables- short term

    21       -  

Interest and other receivables

    76       82  

Total

  $ 293     $ 322  

 

 

As of March 31, 2020, prepaid lease costs and receivables- short term are comprised of $19 in prepaid broker commissions that are expected to be amortized within the next twelve months and $2 in receivables for allocated utility costs.

 

 

6. Inventory

 

Inventory totaled $0 and $12 as of March 31, 2020 and December 31, 2019, respectively. Included within these totals are the following:

 

   

March 31,

   

December 31,

 
   

2020

   

2019

 
                 

Work in progress

  $ -     $ 12  

Total

  $ -     $ 12  

 

12

LIQUIDMETAL TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
For the Three Months Ended March 31, 2020 and 2019
(numbers in thousands, except percentages, share and per share data)
(unaudited)

 

 

 

7. Property and Equipment, net

 

Property and equipment consist of the following:

 

   

March 31,

   

December 31,

 
   

2020

   

2019

 
                 

Land, building, and improvements

  $ 9,587     $ 9,495  

Machinery and equipment

    1,304       1,482  

Computer equipment

    272       272  

Office equipment, furnishings, and improvements

    51       63  

Total

    11,214       11,312  

Accumulated depreciation

    (2,382 )     (2,493 )

Total property and equipment, net

  $ 8,832     $ 8,819  

  

Depreciation expense for three months ended March 31, 2020 and 2019 was $80 and $258, respectively. For the three months ended March 31, 2020 and 2019, $0 and $23 of depreciation expense, respectively, was included in cost of sales and $80 and $235 was included in selling, marketing, general, and administrative expenses, respectively

 

During the three months ended March 31, 2020, the Company disposed of certain manufacturing equipment for gross proceeds of $20. This resulted in a gain on disposal of $20 during the three months ended March 31, 2020. No such sales occurred during the three months ended March 31, 2019.

 

 

8. Equipment Held for Sale

 

The Company previously reclassified $585 in equipment, planned to be disposed of under the 2019 Restructuring Plan, from property and equipment to equipment held for sale on its consolidated balance sheet. The Company has executed a purchase agreement for the equipment, with a negotiated sales price of $600. The sale will be finalized during the first half of 2020, following delivery and other title transfer of equipment to the buyer. No additional adjustments to asset carrying value were recorded as a result of this reclassification. As of March 31, 2020 and December 31, 2019, the Company had received $420 in proceeds from the sale of this equipment, which has been included within accrued liabilities until such time the sale is finalized.

 

 

9. Patents and Trademarks, net

 

Net patents and trademarks totaled $218 and $239 as of March 31, 2020 and December 31, 2019 respectively, and primarily consisted of purchased patent rights and internally developed patents.

 

Purchased patent rights represent the exclusive right to commercialize the bulk amorphous alloy and other amorphous alloy technology acquired from California Institute of Technology (“Caltech”), through a license agreement with Caltech and other institutions. All fees and other amounts payable by the Company for these rights and licenses have been paid or accrued in full, and no further royalties, license fees, or other amounts will be payable in the future under the license agreement.

     

In addition to the purchased and licensed patents, the Company has internally developed patents. Internally developed patents include legal and registration costs incurred to obtain the respective patents. The Company currently holds various patents and numerous pending patent applications in the United States, as well as numerous foreign counterparts to these patents outside of the United States.

 

The Company amortizes capitalized patents and trademarks over an average of 10 to 17 year periods. Amortization expense for patents and trademarks was $21 and $21 for the three months ended March 31, 2020 and 2019, respectively.

 

13

LIQUIDMETAL TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
For the Three Months Ended March 31, 2020 and 2019
(numbers in thousands, except percentages, share and per share data)
(unaudited)

 

 

 

10. Other Assets

 

Other assets totaled $137 and $14 as of March 31, 2020 and December 31, 2019, respectively. Included within these totals are the following:

 

   

March 31,

    December 31,  
   

2020

   

2019

 
                 

Utility deposits

  $ 14     $ 14  

Prepaid lease costs and receivables- long term

    123       -  

Total

  $ 137     $ 14  

 

As of March 31, 2020, prepaid lease costs and receivables- long term are comprised of $77 in unamortized prepaid broker commissions that are not expected to be amortized within the next twelve months and $46 in straight-line rent accruals.

 

 

11. Accrued Liabilities

 

Accrued liabilities totaled $712 and $775 as of March 31, 2020 and December 31, 2019, respectively. Included within these totals are the following:

 

   

March 31,

   

December 31,

 
   

2020

   

2019

 
                 

Accrued payroll, vacation, and bonuses

  $ 143     $ 169  

Accrued severance

    67       67  

Accrued audit fees

    82       119  

Contract liability

    420       420  

Total

  $ 712     $ 775  

 

 

12. Other Long-Term Liabilities  

 

Other long-term liabilities were $899 as of March 31, 2020 and $856 as of December 31, 2019, and consisted of $856 of long-term, aged payables to vendors, individuals, and other third parties that have been outstanding for more than 5 years. The Company is in the process of researching and resolving the balances for settlement and/or escheatment in accordance with applicable state law. Also included in the balance as of March 31, 2020 is $43 in tenant deposits.

 

 

13. Stock Compensation Plans

 

On April 4, 2002, our shareholders and Board of Directors adopted the 2002 Equity Incentive Plan (“2002 Plan”). The 2002 Plan provided for the grant of stock options to officers, employees, consultants, and directors of the Company and its subsidiaries. A total of 10,000,000 shares of our common stock were available to be granted under the 2002 Plan. The 2002 Plan expired by its terms in April 2012 and remains in effect only with respect to the equity awards that have been granted prior to its expiration. As of March 31, 2020 and December 31, 2019, there were 61,000 and 69,000 options, respectively, outstanding under the 2002 Plan.

 

On June 28, 2012, the Company adopted the 2012 Equity Incentive Plan (“2012 Plan”), with the approval of the shareholders, which provides for the grant of stock options to officers, employees, consultants, and directors of the Company and its subsidiaries. The 2012 Plan provides for the granting to employees of incentive stock options within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended, and for the granting to employees and consultants of non-statutory stock options. In addition, the Plan permits the granting of stock appreciation rights, or SARs, with or independently of options, as well as stock bonuses and rights to purchase restricted stock. A total of 30,000,000 shares of the Company’s common stock may be granted under the 2012 Plan, and all options granted under the 2012 Plan had exercise prices that were equal to the fair market value on the date of grant. During the three months ended March 31, 2020, the Company granted no options to purchase shares of common stock. Under this plan, the Company had outstanding grants of options to purchase 5,789,192 and 6,930,445 shares of the Company’s common stock as of March 31, 2020 and December 31, 2019, respectively.

 

On January 27, 2015, the Company adopted its 2015 Equity Incentive Plan (“2015 Plan”), which provided for the grant of stock options to officers, employees, consultants, and directors of the Company and its subsidiaries. A total of 40,000,000 shares of the Company’s common stock are available for issuance under the 2015 Plan. All options granted under the 2015 Plan had exercise prices that were equal to the fair market value on the dates of grant. During the three months ended March 31, 2020, the Company granted no options to purchase shares of common stock. Under this plan, the Company had outstanding grants of options to purchase 12,341,667 and 12,341,667 shares of the Company’s common stock as of March 31, 2020 and December 31, 2019, respectively.

 

Stock based compensation expense attributable to these plans was $92 and $182 for the three months ended March 31, 2020 and 2019, respectively.

 

14

LIQUIDMETAL TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
For the Three Months Ended March 31, 2020 and 2019
(numbers in thousands, except percentages, share and per share data)
(unaudited)

 

 

14. Facility Lease

 

Amounts collected under the facility lease are comprised of base rents and reimbursements for direct facility expenses (property taxes and insurance), common area maintenance, and utilities. Amounts recorded to lease income are comprised of base rents and direct facility expenses, recorded on a straight-line basis over the lease term. Reimbursements for common area maintenance and utility expense are recorded as reductions to like expenses within sales, general, and administrative costs.

 

The future minimum rents due to the Company under the Facility Lease are as follows:

 

Year

 

Base Rents

 
         

2020

  $ 283  

2021

    474  

2022

    486  

2023

    651  

2024

    699  

Thereafter

    237  
    $ 2,830  

 

 

15. Consolidated Statements of Changes in Equity

 

The following table provides the Company’s changes in equity for the three months ended March 31, 2020:

 

   

Preferred Shares

   

Common
Shares

   

Common
Stock

   

Warrants part of Additional Paid-in Capital

   

Additional
Paid-in
Capital

   

Accumulated
Deficit

   

Accumulated Other Comprehensve Income (Loss)

   

Non- Controlling Interest

   

Total

 

Balance, December 31, 2019

    -       914,449,957     $ 914     $ 18,179     $ 286,832     $ (266,284 )   $ 2     $ (75 )   $ 39,568  
                                                                         

Stock-based compensation

                                    92                               92  

Net loss

                                            (746 )             -       (746 )

Other comprehensive loss

                                                    (96 )             (96 )
                                                                         

Balance, March 31, 2020

    -       914,449,957     $ 914     $ 18,179     $ 286,924     $ (267,030 )   $ (94 )   $ (75 )   $ 38,818  

 

The following table provides the Company’s changes in equity for the three months ended March 31, 2019:

 

   

Preferred Shares

   

Common
Shares

   

Common
Stock

   

Warrants part of Additional Paid-in Capital

   

Additional
Paid-in
Capital

   

Accumulated
Deficit

   

Accumulated Other Comprehensve Income (Loss)

   

Non- Controlling Interest

   

Total

 

Balance, December 31, 2018

    -       914,206,832     $ 914     $ 18,179     $ 286,276     $ (258,854 )   $ -     $ (74 )   $ 46,441  
                                                                         

Stock option exercises

            109,792       -               11                               11  

Stock-based compensation

                                    182                               182  

Net loss

                                            (1,768 )                     (1,768 )

Other comprehensive income

                                                    -               -  
                                                                         

Balance, March 31, 2019

    -       914,316,624     $ 914     $ 18,179     $ 286,469     $ (260,622 )   $ -     $ (74 )   $ 44,866  

 

15

LIQUIDMETAL TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
For the Three Months Ended March 31, 2020 and 2019
(numbers in thousands, except percentages, share and per share data)
(unaudited)

 

 

 

16. Accumulated Other Comprehensive Income (Loss) (“AOCI”)

 

The following table presents a summary of the changes in each component of AOCI for the three months ended March 31, 2020:

 

   

Unrealized gains

(losses) on available-for-

sale securities

   

Total

 

Accumulated other comprehensive income (loss), net of tax, as of December 31, 2019

  $ 2     $ 2  
                 

Other comprehensive loss before reclassifications

    (95 )     (95 )

Amounts reclassified from accumulated other comprehensive income (loss)

    (1 )     (1 )

Net increase in other comprehensive income (loss)

  $ (96 )   $ (96 )
                 

Accumulated other comprehensive income (loss), net of tax, as of March 31, 2020

  $ (94 )   $ (94 )

 

There was no activity associated with these components of AOCI for the three months ended March 31, 2019.

 

 

17. Loss Per Common Share

 

Basic earnings per share (“EPS”) is computed by dividing earnings (loss) attributable to common shareholders by the weighted average number of common shares outstanding for the applicable period. Diluted EPS reflects the potential dilution of securities that could share in the earnings.

 

Options to purchase 18,191,859 shares of common stock, at prices ranging from $0.07 to $0.38 per share, were outstanding at March 31, 2020, but were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss. Warrants to purchase 10,066,809 shares of common stock, with a price of $0.07 per share, outstanding at March 31, 2020, were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss.

 

Options to purchase 27,531,332 shares of common stock, at prices ranging from $0.07 to $0.38 per share, were outstanding at March 31, 2019, but were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss. Warrants to purchase 10,066,809 shares of common stock, with a price of $0.07 per share, outstanding at March 31, 2019, were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss.

 

 

18. Related Party Transactions

 

On March 10, 2016, the Company entered into the 2016 Purchase Agreement with Liquidmetal Technology Limited, providing for the purchase of 405,000,000 shares of the Company’s common stock for an aggregate purchase price of $63,400. Liquidmetal Technology Limited was a newly formed company owned by Professor Li. In connection with the 2016 Purchase Agreement and also on March 10, 2016, the Company and Eontec, entered into a license agreement pursuant to which the Company and Eontec entered into a cross-license of their respective technologies. Eontec is a publicly held Hong Kong corporation of which Professor Li is the Chairman and major shareholder. As of March 31, 2020, Professor Li is a greater-than 5% beneficial owner of the Company and serves as the Company’s Chairman, President, and Chief Executive Officer. Equipment and services procured from Eontec were $23 and $0 during the three months ended March 31, 2020 and 2019, respectively.

 

 

 

 

Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

This management’s discussion and analysis should be read in conjunction with the consolidated financial statements and notes included elsewhere in this Quarterly Report on Form 10-Q. All amounts described in this section are in thousands, except percentages, periods of time, and share and per share data.

 

This management’s discussion and analysis, as well as other sections of this Quarterly Report on Form 10-Q, may contain “forward-looking statements” that involve risks and uncertainties, including statements regarding our plans, future events, objectives, expectations, estimates, forecasts, assumptions, or projections. Any statement that is not a statement of historical fact is a forward-looking statement, and in some cases, words such as “believe,” “estimate,” “project,” “expect,” “intend,” “may,” “anticipate,” “plan,” “seek,” and similar words or expressions identify forward-looking statements. These statements involve risks and uncertainties that could cause actual outcomes and results to differ materially from the anticipated outcomes or results, and undue reliance should not be placed on these statements. These risks and uncertainties include, but are not limited to, the matters discussed in Part II herein, under the heading Item 1A. Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019 and other risks and uncertainties discussed in other filings made with the Securities and Exchange Commission (including risks described in subsequent reports on Form 10-Q and Form 8-K and other filings). We disclaim any intention or obligation, other than as required by applicable law, to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

 

 

Overview

 

We are a materials technology company that develops and commercializes products made from amorphous alloys. Our Liquidmetal® family of alloys consists of a variety of proprietary bulk alloys and composites that utilize the advantages offered by amorphous alloy technology. We design, develop, and sell custom products and parts from bulk amorphous alloys to customers in various industries. We also partner with third-party manufacturers and licensees to develop and commercialize Liquidmetal alloy products.

 

Amorphous alloys are, in general, unique materials that are distinguished by their ability to retain a random atomic structure when they solidify, in contrast to the crystalline atomic structure that forms in other metals and alloys when they solidify. Liquidmetal alloys are proprietary amorphous alloys that possess a combination of performance, processing, and potential cost advantages that we believe will make them preferable to other materials in a variety of applications. The amorphous atomic structure of bulk alloys enables them to overcome certain performance limitations caused by inherent weaknesses in crystalline atomic structures, thus facilitating performance and processing characteristics superior in many ways to those of their crystalline counterparts. We believe our alloys and the molding technologies we employ can result in components for many applications that exhibit exceptional dimensional control and repeatability that rivals precision machining, excellent corrosion resistance, brilliant surface finish, high strength, high hardness, high elastic limit, alloys that are non-magnetic, and the ability to form complex shapes common to the injection molding of plastics. All of these characteristics are achievable from the molding process, so design engineers often do not have to select specific alloys to achieve one or more of the characteristics as is the case with crystalline materials. We believe these advantages could result in Liquidmetal alloys supplanting high-performance alloys, such as titanium and stainless steel, and other incumbent materials in a wide variety of applications. Moreover, we believe these advantages could enable the introduction of entirely new products and applications that are not possible or commercially viable with other materials.

 

Our revenues are derived from i) selling our bulk amorphous alloy custom products and parts for applications which include, but are not limited to, non-consumer electronic devices, medical products, automotive components, and sports and leisure goods; ii) selling tooling and prototype parts such as demonstration parts and test samples for customers with products in development; and iii) product licensing and royalty revenue.

 

Our cost of sales consists primarily of the costs of manufacturing, which include raw alloy and direct labor costs. Selling, general, and administrative expenses currently consist primarily of salaries and related benefits, travel, consulting and professional fees, depreciation and amortization, insurance, office and administrative expenses, and other expenses related to our operations.

 

Research and development expenses represent salaries, related benefits expenses, consulting and contract services, expenses incurred for the design and testing of new processing methods, expenses for the development of sample and prototype products, and other expenses related to the research and development of Liquidmetal bulk alloys. Costs associated with research and development activities are expensed as incurred. We plan to enhance our competitive position by improving our existing technologies and developing advances in amorphous alloy technologies. We believe that our research and development efforts will focus on the discovery of new alloy compositions, the development of improved processing technology, and the identification of new applications for our alloys.

 

In July 2019, the Company adopted the 2019 Restructuring Plan pursuant to which the Company elected to wind down its prior manufacturing operations at the Company’s Lake Forest, CA facility and seek to outsource the manufacture of parts utilizing the Company’s technology through domestic and international manufacturing partners. In connection with the 2019 Restructuring Plan, the Company shifted its business strategy from internal manufacture of parts and products for customers toward the use and reliance of outsourced manufacturers, which will initially be Yihao, a China-based company that is an affiliate of our largest beneficial stockholder our CEO and Chairman, Professor Lugee Li.

 

 

Licensing Transactions

 

Eontec License Agreement

 

On March 10, 2016, in connection with the 2016 Purchase Agreement, we entered into a Parallel License Agreement (the “License Agreement”) with DongGuan Eontec Co., Ltd., a Hong Kong corporation (“Eontec”) pursuant to which we each entered into a cross-license of our respective technologies.

 

The License Agreement provides for the cross-license of certain patents, technical information, and trademarks between us and Eontec. In particular, we granted to Eontec a paid-up, royalty-free, perpetual license to our patents and related technical information to make, have made, use, offer to sell, sell, export, and import products in certain geographic areas outside of North America and Europe, and Eontec granted to us a paid-up, royalty-free, perpetual license to Eontec’s patents and related technical information to make, have made, use, offer to sell, sell, export, and import products in certain geographic areas outside of specified countries in Asia. The license granted by us to Eontec is exclusive (including to the exclusion of us) in the countries of Brunei, Cambodia, China (P.R.C and R.O.C.), East Timor, Indonesia, Japan, Laos, Malaysia, Myanmar, Philippines, Singapore, South Korea, Thailand, and Vietnam. The license granted by Eontec to us is exclusive (including to the exclusion of Eontec) in North America and Europe. The cross-licenses are non-exclusive in geographic areas outside of the foregoing exclusive territories.

 

Beyond the License Agreement, we collaborate with Eontec to accelerate the commercialization of amorphous alloy technology. This includes but is not limited to developing technologies to reduce the cost of amorphous alloys, working on die cast machine technology platforms to pursue broader markets, sharing knowledge to broaden our intellectual property portfolio, and utilizing Eontec’s volume production capabilities as a third party contract manufacturer.

 

Eutectix Business Development Agreement

 

On January 31, 2020, we entered into a Business Development Agreement (the “Agreement”) with Eutectix, LLC, a Delaware limited liability company (“Eutectix”), which provides for collaboration, joint development efforts, and the manufacturing of products based on our proprietary amorphous metal alloys. Under the Agreement, we have agreed to license to Eutectix specified equipment owned by us, including two injection molding machines, two diecasting machines, and other machines and equipment, all of which will be used to make product for our customers and Eutectix customers. The licensed machines and equipment represent substantially all of the machinery and equipment currently held by us. We have also licensed to Eutectix various patents and technical information related to our proprietary technology. Under the Agreement, Eutectix will pay us a royalty of six percent (6%) of the net sales price of licensed products sold by Eutectix, and Eutectix will also manufacture product ordered by us. The Agreement has a term of five years, subject to renewal provisions and the ability of either party to terminate earlier upon specified circumstances.

 

Apple License Transaction

 

On August 5, 2010, we entered into a license transaction with Apple Inc. (“Apple”) pursuant to which (i) we contributed substantially all of our intellectual property assets to a newly organized special-purpose, wholly-owned subsidiary, called Crucible Intellectual Property, LLC (“CIP”), (ii) CIP granted to Apple a perpetual, worldwide, fully-paid, exclusive license to commercialize such intellectual property in the field of consumer electronic products, as defined in the license agreement, in exchange for a license fee, and (iii) CIP granted back to us a perpetual, worldwide, fully-paid, exclusive license to commercialize such intellectual property in all other fields of use.

 

Under the agreements relating to the license transaction with Apple, we were obligated to contribute, to CIP, all intellectual property that we developed through February 2012. Subsequently, this obligation was extended to apply to all intellectual property developed through February 2016. We are also obligated to maintain certain limited liability company formalities with respect to CIP at all times after the closing of the license transaction.

 

Other License Transactions

 

On January 31, 2012, we entered into a Supply and License Agreement for a five year term with Engel Austria Gmbh (“Engel”) whereby Engel was granted a non-exclusive license to manufacture and sell injection molding machines to our licensees. Since that time, we and Engel have agreed on an injection molding machine configuration that can be commercially supplied and supported by Engel.  On December 6, 2013, the companies entered into an Exclusivity Agreement for a ten year term whereby we agreed, with certain exceptions and limitations, that we and our licensees would purchase amorphous alloy injection molding machines exclusively from Engel in exchange for certain royalties to be paid by Engel to us based on a percentage of the net sales price of such injection molding machines.

 

Our Liquidmetal Golf subsidiary has the exclusive right and license to utilize our Liquidmetal alloy technology for purposes of golf equipment applications. This right and license is set forth in an intercompany license agreement between Liquidmetal Technologies and Liquidmetal Golf. This license agreement provides that Liquidmetal Golf has a perpetual and exclusive license to use Liquidmetal alloy technology for the purpose of manufacturing, marketing, and selling golf club components and other products used in the sport of golf. We own 79% of the outstanding common stock of Liquidmetal Golf.

 

In March 2009, we entered into a license agreement with Swatch Group, Ltd. (“Swatch”) under which Swatch was granted a non-exclusive license to our technology to produce and market watches and certain other luxury products. In March 2011, this license agreement was amended to grant Swatch exclusive rights as to watches and all third parties (including us), but non-exclusive as to Apple. We will receive royalty payments over the life of the contract on all Liquidmetal products produced and sold by Swatch. The license agreement with Swatch will expire on the expiration date of the last licensed patent.

 

 

Critical Accounting Policies and Estimates

 

The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates and assumptions are based on historical experience and various other factors that are believed to be reasonable under the circumstances. Actual results could differ materially from these estimates under different assumptions or conditions.

 

We believe that the following accounting policies are the most critical to our consolidated financial statements since these policies require significant judgment or involve complex estimates that are important to the portrayal of our financial condition and operating results:

 

 

Revenue recognition

 

Investments in debt securities

 

Impairment of long-lived assets and definite-lived intangibles
 

Deferred tax assets
 

Share based compensation

  Leases

 

Our Annual Report on Form 10-K for the year ended December 31, 2019 (the “2019 Annual Report”) contains further discussions on our critical accounting policies and estimates.

 

 

Results of Operations  

 

Comparison of the three months ended March 31, 2020 and 2019

 

   

For the three months ended March 31,

 
   

2020

         

2019

       
   

in 000's

   

% of Revenue

   

in 000's

   

% of Revenue

 
                             

Revenue:

                           

Products

  $ 46           $ 223        

Licensing and royalties

    25             -        

Total revenue

    71             223        
                             

Cost of sales

    36     51%       179     80%  

Gross profit

    35     49%       44     20%  
                             

Selling, marketing, general and administrative

    987     1390%       1,433     643%  

Research and development

    29     41%       489     219%  

Gain on disposal of long-lived assets

    (20 )   -28%       -     0%  

Total operating expense

    996             1,922        
                             

Operating loss

    (961 )           (1,878 )      
                             

Lease income

    88             -        

Interest and investment income

    127             110        
                             

Net loss

  $ (746 )         $ (1,768 )      

 

Revenue and operating expenses

 

Revenue. Total revenue decreased to $71 for the three months ended March 31, 2020 from $223 the three months ended March 31, 2019. The decrease was attributable to lower volumes associated with the Company’s continued transition from internal manufacturing to outsourced manufacturing. As a result, product revenues during 2020 are expected to be volatile and will likely not be indicative of future results.

 

Cost of sales. Cost of sales was $36, or 51% of total revenue, for the three months ended March 31, 2020, a decrease from $179, or 80% of products revenue, for the three months ended March 31, 2019. The decrease in our cost of sales as a percentage of products revenue for the three months ended March 31, 2020 was primarily attributable to lower production volumes during 2020 and the timing of licensing revenues. If we begin increasing our products revenues with shipments of routine, commercial products and parts through third party contract manufacturers, we expect our cost of sales percentages to decrease, stabilize and be more predictable.

 

Gross profit. Our gross profit decreased to $35 for the three month period ended March 31, 2020 from $44 for the three month period ended March 31, 2019. Our gross profit as a percentage of total revenue, increased to 49% for the three month period ended March 31, 2020 from 20% for the three month period ended March 31, 2019. Early prototype and pre-production orders generally result in a higher cost mix, relative to revenue, than would otherwise be incurred in an on-site production environment, with higher volumes and more established operating processes, or through contract manufacturers. As such, our gross profit percentages have fluctuated and may continue to fluctuate based on volume and quoted production prices per unit and may not be representative of our future business. If we begin increasing our products revenues with shipments of routine, commercial products and parts through future orders to third party contract manufacturers, we expect our gross profit percentages to stabilize, increase, and be more predictable.

 

Selling, marketing, general and administrative. Selling, marketing, general, and administrative expenses were $987 for the three months ended March 31, 2020, compared to $1,433 for the three months ended March 31, 2019. The decrease in expenses was attributable to overall lower costs for employee compensation due to headcount reductions associated with the 2019 Restructuring Plan.

 

Research and development. Research and development expenses were $29 for the three months ended March 31, 2020, compared to $489 for the three months ended March 31, 2019. The decrease in expense was mainly due to reductions in employee compensation, and associated development initiatives, due to headcount reductions associated with the 2019 Restructuring Plan. Going forward, we will continue to perform research and development of new Liquidmetal alloys and related processing capabilities, albeit on a reduced basis in comparison with prior periods.

 

 

Gain on disposal of fixed assets. During the three months ended March 31, 2020, the Company recorded gains on the disposal of fixed assets of $20. Similar gains were not recorded during the three months ended March 31, 2019.

 

Operating loss. Operating loss was $961 for the three months ended March 31, 2020. This compares to $1,878 for the three months ended March 31, 2019. Fluctuations in our operating loss are primarily attributable to variations in operating expenses, as discussed above.

 

We continue to invest in our technology infrastructure to expedite the adoption of our technology, but we have experienced long sales lead times for customer adoption of our technology. Until that time when we can either (i) increase our revenues with shipments of routine, commercial products and parts through third party contract manufacturers or (ii) obtain significant licensing revenues, we expect to continue to have operating losses for the foreseeable future.

 

Other income and expenses

 

Lease income. Lease income relates to straight-line rental income received under the Facility Lease. Such amounts were $88 and $0 for the three months ended March 31, 2020 and 2019, respectively.

 

Interest and investment income. Interest and investment income relates to interest earned from our cash deposits and investments in debt securities for the respective periods. Interest and investment income was $127 and $110 for the three months ended March 31, 2020 and 2019, respectively. The increase during 2020 is due to a higher invested base and overall change in investment strategy to provide increased yields, while preserving liquidity.

 

Liquidity and Capital Resources 

 

Cash used in operating activities

 

Cash used in operating activities totaled $697 and $1,185 for the three months ended March 31, 2020 and 2019, respectively. The cash was primarily used to fund operating expenses related to our business and product development efforts.

 

Cash provided by (used in) investing activities

 

Cash provided by (used in) investing activities totaled $818 and $(184) for the three months ended March 31, 2020 and 2019, respectively. Investing inflows primarily consist of proceeds from the sale of debt securities. Investing outflows primarily consist of purchases of debt securities and capital expenditures for additional production equipment and building improvements.

 

Cash provided by financing activities

 

Cash provided by financing activities totaled $0 and $11 for the three months ended March 31, 2020 and 2019, respectively. Cash provided by financing activities is comprised of cash received for the issuance of shares following the exercise of stock.

 

Financing arrangements and outlook

 

During 2016, we raised a total of $62,700 through the issuance of 405,000,000 shares of our common stock in multiple closings under the 2016 Purchase Agreement. The Company has a relatively limited history of selling bulk amorphous alloy products and components on a mass-production scale. Furthermore, the ability of future contract manufacturers to produce the Company’s products in desired quantities and at commercially reasonable prices is uncertain and is dependent on a variety of factors that are outside of the Company’s control, including the nature and design of the component, the customer’s specifications, and required delivery timelines. These factors have previously required that the Company engage in equity sales under various stock purchase agreements to support its operations and strategic initiatives. As a result of the funding under the 2016 Purchase Agreement, the Company anticipates that its current capital resources, when considering expected losses from operations, will be sufficient to fund the Company’s operations for the foreseeable future.

 

Off Balance Sheet Arrangements 

 

As of March 31, 2020, we did not have any off-balance sheet arrangements.

 

 

Item 3 – Quantitative and Qualitative Disclosures about Market Risk

 

None.

 

Item 4 – Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Under the supervision and with the participation of our management, including our Chief Executive Officer (Principal Executive Officer) and Vice President of Finance (Principal Financial Officer), we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of March 31, 2020. Based on their evaluation, our Chief Executive Officer and Vice President of Finance have concluded that our disclosure controls and procedures were effective as of March 31, 2020.

 

Changes in Internal Control over Financial Reporting.

 

There were no changes in our internal control over financial reporting (as that term is defined in Rules 13a-15(f) or 15d-15(f) under the Exchange Act) during the quarter ended March 31, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 

PART II

OTHER INFORMATION

Item 1 – Legal Proceedings

 

None.

 

Item 1A – Risk Factors

 

For a detailed discussion of the risk factors that should be understood by any investor contemplating an investment in our stock, please refer to Part I, Item 1A “Risk Factors” in the 2019 Annual Report. There have been no material changes from the risk factors previously disclosed in Part I, Item 1A “Risk Factors” in the 2019 Annual Report, except for the addition of the following risk factors:

 

The recent outbreak of COVID-19 and measures intended to prevent its spread may have a significant negative impact on our business, results of operations, and financial condition.

 

The global pandemic resulting from the outbreak of the novel coronavirus (“COVID-19”) has disrupted our operations beginning in March 2020. Federal, state, and local mandates implementing quarantines, “shelter in place” orders, business limitations and/or shutdowns (subject to exceptions for certain essential operations and businesses) aimed at limiting the spread of COVID-19, have resulted in delays to our planned development pipeline. While we are not currently experiencing any supply chain or labor force shortages, our ability to maintain our supply chain and labor force may become challenging as a result of the COVID-19 pandemic. The COVID-19 pandemic and related circumstances may also adversely affect our ability to implement our growth plans, including delays in product development initiatives. As this situation is ongoing and the duration and severity of the COVID-19 pandemic is uncertain at this time, it is difficult to forecast any long-term impacts on our future operating results. However, we expect the COVID-19 pandemic to adversely impact our development pipeline and, depending on the severity and longevity of the COVID-19 pandemic, the efforts taken to reduce its spread and the possibility of a resurgence of the COVID-19 outbreak could impact our asset values, including investments in debt securities and long-lived assets, and have a material adverse effect on our financial results, future operations, and liquidity.

 

Even after the COVID-19 pandemic has subsided, we may continue to experience negative impacts to our financial results due to COVID-19’s global economic impact, including the availability of credit generally, decreases in our customers’ discretionary spending on development projects, and any economic slowdown or recession that has occurred or may occur in the future.

 

Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds

 

During the period covered by this Quarterly Report on Form 10-Q, we did not issue or sell any unregistered equity securities.

 

Item 3 Defaults Upon Senior Securities

 

None.

 

Item 4 – Mine Safety Disclosures

 

None.

 

Item 5 – Other Information

 

None.

 

 

Item 6 – Exhibits

 

The following documents are filed as exhibits to this Report:

 

Exhibit

Number

  Description of Document                                                                                                                        
     

10.1

 

Business Development Agreement dated January 31, 2020, between Liquidmetal Technologies, Inc. and Eutectix, LLC (incorporated by reference to Exhibit 10.1 to the Form 8-K filed on February 5, 2020).

     

10.2

 

Standard Industrial/ Commerical Multi-Tenant Lease – Net, dated January 23, 2020 between 20321 Valencia, LLC and Matterhackers, Inc (incorporated by reference to Exhibit 10.1 to the Form 8-K filed on January 29, 2020).

     

31.1

 

Certification of Principal Executive Officer, Lugee Li, as required by Section 302 of the Sarbanes-Oxley Act of 2002.

     

31.2

 

Certification of Principal Financial Officer, Bryce Van, as required by Section 302 of the Sarbanes-Oxley Act of 2002.

     

32.1

 

Certification of Chief Executive Officer, Lugee Li, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

     

32.2

 

Certification of Vice President of Finance, Bryce Van, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

     

101.1

 

The following financial statements from Liquidmetal Technologies, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2020 (unaudited), formatted in XBRL: (i) Consolidated Balance Sheets as of March 31, 2020 and December 31, 2019, (ii) Consolidated Statements of Operations for the three months ended March 31, 2020 and 2019, (iii) Consolidated Statements of Comprehensive Loss for the three months ended March 31, 2020 and 2019,  (iv) Consolidated Statements of Cash Flows for the three months ended March 31, 2020 and 2019, and (v) Notes to Consolidated Financial Statements.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

LIQUIDMETAL TECHNOLOGIES, INC.

 

 

(Registrant)

 

 

 

 

Date: May 5, 2020

/s/ Lugee Li

 

 

Lugee Li

 

 

President and Chief Executive Officer

 

 

(Principal Executive Officer)

 

 

 

 

 

 

 

Date: May 5, 2020

/s/ Bryce Van

 

 

Bryce Van

 

 

Vice President of Finance

 

 

(Principal Financial and Accounting Officer)

 

 

25